Clinical, Economic, and Patient-Reported Benefits of Connected Insulin Pen Systems: A Systematic Literature Review

Cranston, Iain; Jamdade, Vinayak S; Liao, Birong; Newson, Rachel S.

doi:10.1007/s12325-023-02478-1

Cited by 9 publications

(1 citation statement)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“… Perfil del paciente. Los pacientes con perfil para el uso de esta tecnología son aquellos con pobre control y de gran complejidad clínica que además requieren de flexibilidad, simplicidad y que se pueden beneficiar de la asesoría en la adherencia a la terapia o de recordatorios de dosis de insulina, permitiendo identificar precozmente los criterios de escalonamiento tecnológico (75)(76)(77).…”

unclassified

Perfilando la tecnología en diabetes

Buitrago-Gómez,

Jimenez-Salazar,

Delgado

et al. 2024

Rev.ACE

View full text Add to dashboard Cite

Contexto: la tecnología ha revolucionado el enfoque del manejo del paciente con diagnóstico de diabetes. Clásicamente, se ha dividido en proximal y distal, donde el enfoque proximal comprende tres áreas dadas por: suministro de insulina, monitoreo de glucosa y sistemas de suministro de insulina que responden a la glucosa. Objetivo: realizar una revisión narrativa que apoye la decisión acerca del perfil de los pacientes que mejor se ajusta a cada tipo de tecnología proximal. Metodología: se realizó una revisión narrativa de la literatura, mediante búsqueda de artículos científicos en Medline, entre los años 2015 y 2023. Resultados: se seleccionaron 99 artículos y se describen los perfiles más recomendados de los pacientes para seleccionar la tecnología que más se ajusta a ellos de acuerdo con sus características. Conclusiones: alcanzar el control sin hipoglucemias en diabetes es una meta a la que la tecnología nos acerca cada vez más, sin embargo, los costos limitan su generalización, por lo que se requiere conocer el perfil de cada paciente para seleccionar adecuadamente la herramienta tecnológica más acertada para cada caso individual.

show abstract

unclassified

Perfilando la tecnología en diabetes

Buitrago-Gómez,

Jimenez-Salazar,

Delgado

et al. 2024

Rev.ACE

View full text Add to dashboard Cite

show abstract

The use of technology in type 2 diabetes and prediabetes: a narrative review

Liarakos,

Lim,

Leelarathna

et al. 2024

Diabetologia

View full text Add to dashboard Cite

The increasing incidence of type 2 diabetes, which represents 90% of diabetes cases globally, is a major public health concern. Improved glucose management reduces the risk of vascular complications and mortality; however, only a small proportion of the type 2 diabetes population have blood glucose levels within the recommended treatment targets. In recent years, diabetes technologies have revolutionised the care of people with type 1 diabetes, and it is becoming increasingly evident that people with type 2 diabetes can also benefit from these advances. In this review, we describe the current knowledge regarding the role of technologies for people living with type 2 diabetes and the evidence supporting their use in clinical practice. We conclude that continuous glucose monitoring systems deliver glycaemic benefits for individuals with type 2 diabetes, whether treated with insulin or non-insulin therapy; further data are required to evaluate the role of these systems in those with prediabetes (defined as impaired glucose tolerance and/or impaired fasting glucose and/or HbA1c levels between 39 mmol/mol [5.7%] and 47 mmol/mol [6.4%]). The use of insulin pumps seems to be safe and effective in people with type 2 diabetes, especially in those with an HbA1c significantly above target. Initial results from studies exploring the impact of closed-loop systems in type 2 diabetes are promising. We discuss directions for future research to fully understand the potential benefits of integrating evidence-based technology into care for people living with type 2 diabetes and prediabetes. Graphical Abstract

show abstract

Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

Tejera-Pérez,

Chico,

Azriel-Mira

et al. 2023

Diabetes Ther

View full text Add to dashboard Cite

Undoubtedly, technological advances have revolutionised diabetes management in recent years. The development of advanced closed hybrid loop insulin pumps or continuous glucose monitoring (CGM) systems, among others, have increased the quality of life and improved glycaemic control of people with diabetes. However, only some patients have access to such technology, and only some want to use it. CGM has become much more widespread, but in terms of insulin delivery, most people with type 1 diabetes (T1D) and almost all people with type 2 diabetes (T2D) on insulin therapy are treated with multiple-dose insulin injections (MDI) rather than an insulin pump. For these patients, using connected insulin pens or caps has shown benefits in reducing missed insulin injections and promoting correct administration over time. In addition, using these devices improves the quality of life and user satisfaction. The integration of insulin injection and CGM data facilitates both users and the healthcare team to analyse glucose control and implement appropriate therapeutic changes, reducing therapeutic inertia. This expert’s recommendation reviews the characteristics of the devices marketed or in the process of being marketed and their available scientific evidence. Finally, it suggests the profile of users and professionals who would benefit most, the barriers to its generalisation and the changes in the care model that implementing these devices can bring with it.

show abstract

Clinical, Economic, and Patient-Reported Benefits of Connected Insulin Pen Systems: A Systematic Literature Review

Cited by 9 publications

References 42 publications

Perfilando la tecnología en diabetes

Perfilando la tecnología en diabetes

The use of technology in type 2 diabetes and prediabetes: a narrative review

Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN)

Contact Info

Product

Resources

About